Not amyloids but C1q

Alzheimer; News from the web:

In a groundbreaking study from Stanford University School of Medicine, researchers detailed the significance of a protein called C1q, which was previously known as the initiator of the immune system response. After analyzing brain tissue in mice of varying ages, as well as postmortem samples of a 2-month-old infant and an elderly person, they discovered that C1q exponentially increases in the aging brain – creating as much as a 300-fold buildup. Comparatively, most age-associated increases of proteins in the brain are only three- or four-fold

Read all about it HERE

visit us at AlzheimerHeadlines.com

It’s not Alzheimer!

Alzheimer; News from the web:

The last thing most patients do when they receive an Alzheimer’s diagnosis is seek another diagnosis.

But research shows that up to 5 percent of dementia cases are misdiagnosed cases of a treatable but largely unknown condition called “normal pressure hydrocephalus.”

Read all about it HERE

visit us at AlzheimerHeadlines.com

Alzheimer research Breakthrough

Alzheimer; News from the web:

A Lower Hutt team of researchers has made a significant contribution to the hunt for a treatment for Alzheimer’s disease.

Chemists at Callaghan Innovation (CI, formerly IRL Ltd), working from Gracefield, are the first in the world to find a way to synthesise a type of complex sugar that shows signs it could control the process that leads to the common brain disease.

Read all about it HERE

visit us at AlzheimerHeadlines.com